The National Institute for Neurological Disorders and Stroke (NINDS) is considering issuing a contract that would provide resources and expertise to help us accelerate therapeutics development for Spinal Muscular Atrophy (SMA). NINDS is attempting to identify competent sources to establish and coordinate pre-clinical research activities leading to a new treatment for SMA, and is seeking input from experienced sources into the design of a proposed statement of work for the project.